| Report ID | 273867 |
| Drug Identification Number | 02486296 |
| Brand name | TRI-JORDYNA 21 |
| Common or Proper name | TRI JORDYNA |
| Company Name | GLENMARK PHARMACEUTICALS CANADA INC. |
| Market Status | MARKETED |
| Active Ingredient(s) | NORGESTIMATE NORGESTIMATE NORGESTIMATE ETHINYL ESTRADIOL ETHINYL ESTRADIOL ETHINYL ESTRADIOL |
| Strength(s) | 0.25MG 0.18MG 0.215MG 0.035MG 0.035MG 0.035MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 21's |
| ATC code | G03AB |
| ATC description | |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2025-12-09 |
| Actual start date | 2025-12-09 |
| Estimated end date | 2026-03-14 |
| Actual end date | |
| Shortage status | Actual shortage |
| Updated date | 2026-02-13 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 1600 STEELES AVE. W., SUITE 407 CONCORD, ONTARIO CANADA L4K 4M2 |
| Company contact information |
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2026-02-13 | French | Compare |
| v3 | 2026-02-13 | English | Compare |
| v2 | 2025-12-09 | French | Compare |
| v1 | 2025-12-09 | English | Compare |
Showing 1 to 4 of 4